Literature DB >> 1958380

Presence of platelet-derived growth factor in normal and fibrotic lung is specifically associated with interstitial macrophages, while both interstitial macrophages and alveolar epithelial cells express the c-sis proto-oncogene.

J M Vignaud1, M Allam, N Martinet, M Pech, F Plenat, Y Martinet.   

Abstract

Normal lung structure is maintained by the presence of mesenchymal cells and their extracellular matrix products. The slow normal turnover of these cells is disrupted in fibrotic disorders, resulting in the in situ accumulation of mesenchymal cells and their extracellular matrix leading to a progressive alveolar wall thickening. Idiopathic pulmonary fibrosis (IPF) is a chronic fibrotic disorder of the lung characterized by a diffuse interstitial and intra-alveolar inflammation dominated by macrophages and polymorphonuclear neutrophils. Evaluation of alveolar macrophages (AM) obtained by bronchoalveolar lavage has previously shown that AM from normal individuals spontaneously release small amounts of platelet-derived growth factor (PDGF), a chemotactic and growth factor for mesenchymal cells, whereas AM from IPF patients spontaneously release increased amounts of biologically active PDGF, suggesting its involvement in mesenchymal cell accumulation. However, other cells such as endothelial cells and vascular smooth muscle cells can also release PDGF in vitro. In order to specify PDGF location in lung parenchyma, open lung biopsies from normal individuals and IPF patients were examined by immunohistochemistry using an anti-PDGF antibody and by in situ hybridization using PDGF A-chain and B-chain gene probes. In normal as well as in fibrotic lung, PDGF was only present in relation with interstitial macrophages but not with any other inflammatory cells or mesenchymal cells. Furthermore, the percentage of PDGF-positive macrophages in IPF was 3-fold increased in comparison to normal lung. In addition, the percentage of PDGF-positive macrophages was the same in fibrotic and nonfibrotic areas of IPF lungs.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1958380     DOI: 10.1165/ajrcmb/5.6.531

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  18 in total

1.  The expression of PDGF-B chain mRNA in lung tissue from rats repeatedly infected with mycoplasma pneumoniae.

Authors:  J Liu; D Peng; Z Zhu; D Che; M Yang; D Li
Journal:  J Tongji Med Univ       Date:  1998

Review 2.  Cytokines and pulmonary fibrosis.

Authors:  J Gauldie; M Jordana; G Cox
Journal:  Thorax       Date:  1993-09       Impact factor: 9.139

3.  Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor.

Authors:  G W Hoyle; J Li; J B Finkelstein; T Eisenberg; J Y Liu; J A Lasky; G Athas; G F Morris; A R Brody
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

4.  Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis.

Authors:  Y Miyazaki; K Araki; C Vesin; I Garcia; Y Kapanci; J A Whitsett; P F Piguet; P Vassalli
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

5.  Association of platelet-derived growth factor-B chain with simian human immunodeficiency virus encephalitis.

Authors:  Raghava Potula; Navneet Dhillion; Yongjun Sui; Christopher A Zien; Keiko Funa; David Pinson; Matthew S Mayo; Dinesh K Singh; Opendra Narayan; Shilpa Buch
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

6.  Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products.

Authors:  B Crestani; P Cornillet; M Dehoux; C Rolland; M Guenounou; M Aubier
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

Review 7.  New perspectives on basic mechanisms in lung disease. 1. Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitis.

Authors:  M N Sheppard; N K Harrison
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

8.  Localization of surfactant protein A (SP-A) in alveolar macrophage subpopulations of normal and fibrotic rat lung.

Authors:  M Kasper; K Sakai; R Koslowski; K W Wenzel; G Haroske; D Schuh; M Müller
Journal:  Histochemistry       Date:  1994-11

Review 9.  Determinants of initiation and progression of idiopathic pulmonary fibrosis.

Authors:  Robert Matthew Kottmann; Christopher M Hogan; Richard P Phipps; Patricia J Sime
Journal:  Respirology       Date:  2009-09       Impact factor: 6.424

Review 10.  Macrophage heterogeneity in respiratory diseases.

Authors:  Carian E Boorsma; Christina Draijer; Barbro N Melgert
Journal:  Mediators Inflamm       Date:  2013-02-27       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.